New Risks, New Rewards, New Exposure

Published date24 June 2020
Subject MatterCMS,Medicare,OIG,Anti-Kickback Statute,Medicaid,Value-Based Purchasing,Affordable Care Act,Prescription Drugs,Reimbursements,Medicare Part B,Drug Pricing,Pharmaceutical Industry,Proposed Rules,MDRP,Department of Health and Human Services (HHS)
AuthorSeth Lundy,David Farber,John Shakow,Elizabeth Lindquist,Preeya Pinto,Michael Dohmann
Law FirmKing & Spalding

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT